Prilenia Hayden News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prilenia hayden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prilenia Hayden Today - Breaking & Trending Today

Huntington's disease setback for Roche shifts the research spotlight to Prilenia


Video
Blog
Blog
Blog
11 May, 2021
Author
Etain Lavelle
Huntington s disease research suffered a double whammy after Swiss pharmaceutical giant Roche Holding AG halted late-stage trials of an experimental medicine and Wave Life Sciences Ltd. abandoned two drug studies for futility.
Roche stopped dosing patients with tominersen after an independent data monitoring committee questioned whether the drug s benefits outweighed its risks.
Obviously, it s a very sad situation when we have to stop a pivotal program in a disease like Huntington s where there s such a high unmet need and such a terrible impact on these patients and their families, Bill Anderson, head of Roche s pharmaceuticals business, said on a call with reporters following Roche s first-quarter results. It s a major setback for the field. But we will do everything we can to learn from the work that s been done. And if there s a way forwa ....

South Africa , United Kingdom , Bill Anderson , Roche Anderson , Prilenia Hayden , Michael Hayden , Israel Teva Pharmaceutical Industries Ltd , University Of British Columbia , Voyager Therapeutics Inc , Wave Life Sciences Ltd , Drug Administration , Roche Holding , Wave Life Sciences , Netherlands Based Prilenia Therapeutics , Teva Pharmaceutical Industries Ltd , Spark Therapeutics , British Columbia , ஒன்றுபட்டது கிஂக்டம் , ர சி து ஆண்டர்சன் , ரோச் ஆண்டர்சன் , மைக்கேல் ஹைடன் , இஸ்ரேல் தேவா மருந்து தொழில்கள் லிமிடெட் , பல்கலைக்கழகம் ஆஃப் பிரிட்டிஷ் கொலம்பியா , வோயேஜர் சிகிச்சை இன்க் , அலை வாழ்க்கை அறிவியல் லிமிடெட் , ரோச் வைத்திருத்தல் ,